Industries > Healthcare > Healthcare Market Research and Consulting Services

Healthcare Market Research and Consulting Services

Using AI/ML tools, healthcare market research consulting services provide white-label analysis with accurate, thorough coverage, a better return on investment and a faster turnaround.

Blogs | Wearable Tech: A Promise to Revolutionize Healthcare

Healthcare Market Research Services and Offerings

Being one of the few healthcare market research firms in the UK, SGA has helped pharmaceutical, medical device and life sciences companies boost their sales and market shares over the past 10 years. Unlike many other healthcare market research companies, our experts ensure that your company data is secure with us. Our growth has been mainly in the healthcare data management domain, followed by market access, market entry and competitive intelligence. We are regarded as one of the UK's top healthcare market research companies. In recent years, we have expanded our services into new categories such as robotic data automation, ESG-pharma, and health economics and outcomes research (HEOR) to provide the finest healthcare market research, UK services to our business clients in the UK. 

SGA has established itself as the top provider of healthcare market research services internationally using AI and ML methods. It provides the most pertinent data metrics and insights into the niche areas of the healthcare business. Our experts have expertise in both developed and developing markets. 

Healthcare market research services and offerings

What We Offer

Our healthcare market research team helps clients co-create their strategic roadmaps, communicate their plans to the right audience, and offer customized solutions for new product market entry strategies.

SG Analytics (SGA) helps you generate evidence of the value of a new drug or product for reimbursement and healthcare payers using artificial intelligence (AI)/machine language (ML) tools for crisp and precise solutions.

Approximately $500billionworth of M&A deals are waiting to happen. We can help you tap into the right audience, tech due diligence, and healthcare intel and cut down the lag phase from search to ‘go to market’.

An amalgamation of strategies, marketing, and competitive intelligence (CI) for pharma, devices and diagnostic companies that are planning to introduce or check the adequate supply of products amid the market competition and price war.


We help you evaluate new entrant threats, track the current players and technology, check the pulse and power of the suppliers and buyers, and the availability of substitutes and counterfeits.

Identification, mapping, and engagement of key opinion leaders (KOL) in healthcare through our in-house panel makes us the most preferred partner in the industry.


Industry Leader

SGA thrives by its brand promise – ‘Life’s Possible’, and is recognised as the UK’s most trusted healthcare market research company.

12+ Languages

Language capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali and English experts (US/UK).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetisable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with analytical and ML/AI capabilities, helps in presenting credible competitive information.

Who We Work With


SG Analytics Healthcare Whitepaper - Orthodontics-Go or No Go APAC


“Go or No Go APAC” – Who wins the race after COVID-19?

While businesses run on visibility, orthodontics in the dental industry is booming under the ‘invisible orthodontics’ sub-segment. The rise of...

Breast cancer market in USA


The US Breast Cancer Market

The year 2022 initiated a...


Hot Investment Trends in Pharma and Healthcare Segments

The Pharma and Healthcare segments are undergoing constant changes. Post pandemic, there has been an increase in traction for investment in the...

We strongly believe in women power. Our research team consists of more female than male i.e., 55?males, and consists of PhDs, M Pharm, D Pharm, Postgraduate in Finance, Biotech, and MBAs.

Our pharmaceuticals, medical devices, life sciences and med-tech expertise guarantee high-quality, white-labelled research coverage.